典型文献
Disease progression after discontinuation of corticosteroid treatment in a COVID-19 patient with ARDS
文献摘要：
Excessive acute inflammatory response in coronavirus-induced disease 2019 (COVID-19) patients results in multiple organ injury, especially acute respiratory distress syndrome (ARDS), contributing to a high mortality of the disease[1,2]. More evidence showed that corticosteroid, an immunomodulatory agent, reduces both the need of invasive mechanical ventilation and lowers the mortality of severe COVID-19 patients. However, its optimal dose and therapeutic duration is still ambiguous. The RECOVERY trial revealed that using corticosteroid up to 10 days reduced the mortality of hospitalized COVID-19 patients[3] and a finding also upheld by a meta-analysis by Cano et al.[4]. To the best of our knowledge, currently, there is no study evaluating disease progression after discontinuation of corticosteroid treatment in COVID-19 patients with ARDS.
文献关键词：
中图分类号：
作者姓名：
Lam Nguyen-Ho
作者机构：
Department of Internal Medicine,University of Medicine and Pharmacy at Ho Chi Minh City,Vietnam;University Medical Center HCMC,Ho Chi Minh City,Vietnam
文献出处：
引用格式：
[1]Lam Nguyen-Ho-.Disease progression after discontinuation of corticosteroid treatment in a COVID-19 patient with ARDS)[J].亚太热带医药杂志（英文版）,2022(01):47-48
A类：
Cano
B类：
Disease,progression,after,discontinuation,corticosteroid,treatment,ARDS,Excessive,acute,inflammatory,response,coronavirus,induced,disease,patients,results,multiple,organ,injury,especially,respiratory,distress,syndrome,contributing,high,mortality,More,evidence,showed,that,immunomodulatory,agent,reduces,both,need,invasive,mechanical,ventilation,lowers,severe,However,its,optimal,dose,therapeutic,duration,still,ambiguous,RECOVERY,trial,revealed,using,days,reduced,hospitalized,finding,also,upheld,by,meta,analysis,To,best,our,knowledge,currently,there,study,evaluating
AB值：
0.614941
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
